25 renewable-energy "The Norwegian University of Life Sciences (NMBU)" research jobs at Center for Biologics Evaluation and Research (CBER)

FDA Post-Doctoral Fellowship: Cell Manufacturing

, conditions, or injury. The project will employ a variety of approaches including large scale cell manufacturing, extracellular vesicle manufacturing and characterization, biomaterials, high content imaging

FDA Postdoctoral Fellowship: Cell and Gene Therapy

diseases, conditions, or injury.  The successful candidate will perform laboratory research on projects related to cell and gene therapy. The candidate will use advanced manufacturing tools and strategies

FDA Fellowship in Understanding the Role and Regulation of Hemostatic Proteins in Patients with Sickle Cell Disease

interested in understanding the role and regulation of hemostatic proteins and the impact of unbalanced VWF:ADAMTS13 in patients with sickle cell disease (SCD). This is an exceptional opportunity for to learn

FDA Fellowship in Immune Responses to Influenza COVID and Respiratory Syncytia Virus and Adjuvanted Vaccines

: The candidate will be trained in advanced techniques developed in the lab including in vitro cell cultures (viral infections); virus neutralization assays, cytokine production; whole genome gene-fragment phage

FDA Fellowship in the Improvement of Safety and Efficacy of Influenza Vaccines by Investigation of Candidate Vaccine Virus

. Anticipated Appointment Start Date: June 1, 2024.  Start date is flexible and will depend on a variety of factors. Appointment Length: The appointment will initially be for one year but may be renewed upon

FDA Research Fellow: Immunity to Intracellular Bacteria

 factors. Appointment Length: The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability of funds. Level of Participation

FDA Cellular Therapeutics Fellowship

*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available immediately in the Division of Cell Therapy (DCT2), within the Office of Cellular

FDA Post-doctoral Fellowship in SARS-CoV-2 Immune Evasion and Variant Evolution

for two years, but may be renewed upon recommendation of FDA and is contingent on the availability of funds. Level of Participation: The appointment is full time. Citizenship Requirements: This opportunity

FDA Fellowship in the Evaluation of the Safety and Efficacy of Live Attenuated Leishmania Parasite Vaccines

the application of state of the art methods such as single cell RNA-Seq/ATAC seq/spatial transcriptomics on preclinical animal models towards understanding the mechanisms of pathogenesis and defining correlates

FDA Fellowship in Blood Platelet and Protein Particle Research

flexible and will depend on a variety of factors. Appointment Length: The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability